Systems and methods for expressionbased discrimination of distinct clinical disease states in prostate cancer

Details for Australian Patent Application No. 2009253675 (hide)

Owner GenomeDx Biosciences, Inc.

Inventors Davicioni, Elai

Agent Griffith Hack

Pub. Number AU-A-2009253675

PCT Pub. Number WO2009/143603

Priority 61/056,827 28.05.08 US

Filing date 28 May 2009

Wipo publication date 3 December 2009

International Classifications

C40B 40/06 (2006.01) Libraries , e.g. arrays, mixtures

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C40B 30/04 (2006.01) Methods of screening libraries - by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding

Event Publications

27 January 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 22 Dec 2010

27 January 2011 PCT application entered the National Phase

  PCT publication WO2009/143603 Priority application(s): WO2009/143603

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009253682-Modulating interstitial pressure and oncolytic viral delivery and distribution

2009253674-Coating compositions and processes for making the same